Oxford vaccine success is ‘wider win for academic science’

Comparisons with big pharma distract from ‘amazing’ achievement that will lead to long-term dividends for science, say experts

Published on

December 1, 2020

Last updated

December 2, 2020

Twitter: @jgro_the

Researcher at the Federal University of São Paulo

Source: Reuters

Trials for the Oxford/AstraZeneca vaccine were done at the Federal University of São Paulo

Read more about

Read more about:

Science, technology, engineering and mathematics (STEM)

POSTSCRIPT:

Print headline: Oxford result is ‘wider win for academic science’

Register to continue

Why register?

Registration is free and only takes a moment
Once registered, you can read 3 articles a month
Sign up for our newsletter

Subscribe

Or subscribe for unlimited access to:

Unlimited access to news, views, insights & reviews
Digital editions
Digital access to THE’s university and college rankings analysis

Please or to read this article.

Related articles

Stewards open the gates to ticket holders at a festival

Oxford to consider socioeconomic data in PhD applications

Pilot scheme to promote diversity in doctoral study will also include anonymisation of applications

23 September

Robert Winston: UK government made ‘colossal errors’ on coronavirus

Labour peer and scientist also worries that ‘moonshot’ ambitions for 10 million tests a day is setting up science to fail

23 September

Sunetra Gupta: social media attacks ‘stifling coronavirus debate’

Oxford epidemiologist and lockdown critic says ‘puritanical’ criticism of idea of herd immunity has chilled legitimate scientific and policy debate

16 September

Man wearing a mask with the South Korean flag

South Korea launches Covid crackdown before entrance exam

Experts say the crisis should have been used as a good opportunity to rethink a notoriously stressful assessment system

28 November

Related universities

Sponsored